Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice
Chronic infection with hepatitis C virus (HCV) remains a leading cause of liver-related pathologies and a global health problem, currently affecting more than 71 million people worldwide. The development of a prophylactic vaccine is much needed to complement the effective antiviral treatment availab...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2021
|
| _version_ | 1826292762406813696 |
|---|---|
| author | Dobrica, M van Eerde, A Tucureanu, C Onu, A Paruch, L Caras, I Vlase, E Steen, H Haugslien, S Alonzi, D Zitzmann, N Bock, R Dubuisson, J Popescu, C Stavaru, C Liu Clarke, J Branza‐Nichita, N |
| author_facet | Dobrica, M van Eerde, A Tucureanu, C Onu, A Paruch, L Caras, I Vlase, E Steen, H Haugslien, S Alonzi, D Zitzmann, N Bock, R Dubuisson, J Popescu, C Stavaru, C Liu Clarke, J Branza‐Nichita, N |
| author_sort | Dobrica, M |
| collection | OXFORD |
| description | Chronic infection with hepatitis C virus (HCV) remains a leading cause of liver-related pathologies and a global health problem, currently affecting more than 71 million people worldwide. The development of a prophylactic vaccine is much needed to complement the effective antiviral treatment available and achieve HCV eradication. Current strategies focus on increasing the immunogenicity of the HCV envelope glycoprotein E2, the major target of virus neutralizing antibodies, by testing various expression systems or manipulating the protein conformation and the N-glycosylation pattern.
Here we report the first evidence of successful production of the full-length HCV E2 glycoprotein in Nicotiana benthamiana, by using the Agrobacterium-mediated transient expression technology. Molecular and functional analysis showed that the viral protein was correctly processed in plant cells and achieved the native folding required for binding to CD81, one of the HCV receptors. N-glycan analysis of HCV-E2 produced in N. benthamiana and mammalian cells indicated host-specific trimming of mannose residues and possibly, protein trafficking. Notably, the plant-derived viral antigen triggered a significant immune response in vaccinated mice, characterized by the presence of antibodies with HCV neutralizing activity. Together, our study demonstrates that N. benthamiana is a viable alternative to costly mammalian cell cultures for the expression of complex viral antigens and supports the use of plants as cost-effective production platforms for development of HCV vaccines.
|
| first_indexed | 2024-03-07T03:19:42Z |
| format | Journal article |
| id | oxford-uuid:b7024ec2-fb75-45f7-a704-709d99b6bbc1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:19:42Z |
| publishDate | 2021 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:b7024ec2-fb75-45f7-a704-709d99b6bbc12022-03-27T04:45:26ZHepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated miceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b7024ec2-fb75-45f7-a704-709d99b6bbc1EnglishSymplectic ElementsWiley2021Dobrica, Mvan Eerde, ATucureanu, COnu, AParuch, LCaras, IVlase, ESteen, HHaugslien, SAlonzi, DZitzmann, NBock, RDubuisson, JPopescu, CStavaru, CLiu Clarke, JBranza‐Nichita, NChronic infection with hepatitis C virus (HCV) remains a leading cause of liver-related pathologies and a global health problem, currently affecting more than 71 million people worldwide. The development of a prophylactic vaccine is much needed to complement the effective antiviral treatment available and achieve HCV eradication. Current strategies focus on increasing the immunogenicity of the HCV envelope glycoprotein E2, the major target of virus neutralizing antibodies, by testing various expression systems or manipulating the protein conformation and the N-glycosylation pattern. Here we report the first evidence of successful production of the full-length HCV E2 glycoprotein in Nicotiana benthamiana, by using the Agrobacterium-mediated transient expression technology. Molecular and functional analysis showed that the viral protein was correctly processed in plant cells and achieved the native folding required for binding to CD81, one of the HCV receptors. N-glycan analysis of HCV-E2 produced in N. benthamiana and mammalian cells indicated host-specific trimming of mannose residues and possibly, protein trafficking. Notably, the plant-derived viral antigen triggered a significant immune response in vaccinated mice, characterized by the presence of antibodies with HCV neutralizing activity. Together, our study demonstrates that N. benthamiana is a viable alternative to costly mammalian cell cultures for the expression of complex viral antigens and supports the use of plants as cost-effective production platforms for development of HCV vaccines. |
| spellingShingle | Dobrica, M van Eerde, A Tucureanu, C Onu, A Paruch, L Caras, I Vlase, E Steen, H Haugslien, S Alonzi, D Zitzmann, N Bock, R Dubuisson, J Popescu, C Stavaru, C Liu Clarke, J Branza‐Nichita, N Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title | Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title_full | Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title_fullStr | Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title_full_unstemmed | Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title_short | Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice |
| title_sort | hepatitis c virus e2 envelope glycoprotein produced in nicotiana benthamiana triggers humoral response with virus neutralizing activity in vaccinated mice |
| work_keys_str_mv | AT dobricam hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT vaneerdea hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT tucureanuc hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT onua hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT paruchl hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT carasi hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT vlasee hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT steenh hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT haugsliens hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT alonzid hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT zitzmannn hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT bockr hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT dubuissonj hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT popescuc hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT stavaruc hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT liuclarkej hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice AT branzanichitan hepatitiscviruse2envelopeglycoproteinproducedinnicotianabenthamianatriggershumoralresponsewithvirusneutralizingactivityinvaccinatedmice |